Radiology AI worklist integration evaluation should begin with a narrow question: what does the system actually control, and what evidence would show that the integrated workflow behaves as intended? The ACR–SIIM practice parameter frames deployment as introducing an AI solution into clinical workflow for use in patient care by qualified end-users, a definition that makes integration an operational event rather than a model performance metric [1]. A useful evaluation therefore separates three layers: the model's diagnostic behavior, the routing and prioritization logic that moves studies, and the human interface where radiologists encounter results. Each layer has different owners, inputs, outputs, and failure modes. Treating them as one undifferentiated product obscures the specific decisions that determine whether an AI worklist tool helps, confuses, or simply adds another queue to manage. The evaluation should document those boundaries explicitly before any prospective trial begins.
Record Ownership and the Triage Signal Boundary
A worklist triage tool produces a signal that must be owned by someone or something before it changes queue position. The AMA AI Specialty Collaborative describes radiology triage signals for suspected intracranial hemorrhage or large vessel occlusion interacting with other applications to inform worklist priorities, trigger mobile alerts, populate dashboards, or initiate EHR tasks [4]. That description makes the signal a shared artifact, not a self-contained result. Organizations should document which systems receive the triage signal, how priorities are established through queue positions, alerts, and timers, and who is responsible for follow-up actions [4]. Without that record, the same AI output can produce different worklist behavior depending on local routing configuration.
The ACR–SIIM parameter assigns imaging informatics and IT professionals responsibility for configuring the necessary infrastructure for an AI solution, including hardware and software specifications [1]. This places integration ownership partly outside the radiology group. The Radiology AI Council experience reinforces that institutional knowledge about deployment is often not well documented, and that AI model integration can interact with multiple systems, requiring new standard operating procedures [3]. A worklist evaluation should therefore name the system of record for triage state, the component that applies prioritization rules, and the party accountable when a flagged study does not surface as expected. These are configuration questions, not model questions, and they cannot be answered by vendor accuracy claims.
Inputs, Outputs, and Interface Distinctions
Standalone computer-aided detection triage tools differ from diagnostic tools in what they display. The AMA guide states that standalone CADt user interfaces are limited to case status, timestamps, and routing logic rather than image findings, because image highlighting is a function of CADe and CADx tools [4]. This distinction matters for evaluation because a worklist tool may never show radiologists why a case was prioritized. The ACR–SIIM parameter similarly separates CADe, worklist triage, CADx, and quantification tools within its scope [1]. An evaluation should record whether the interface under review is a triage-only surface or a combined display, and whether the radiologist can distinguish an AI result in progress from an exception where the result will never return [6].
Input fidelity is a separate evaluation concern. The ACR–SIIM parameter notes that performance changes can be caused by multiple factors, including changes in the type of inputs provided to the model [1]. A worklist tool that receives different series, protocols, or patient contexts than those used during validation may behave differently even if the model is unchanged. The Radiology AI Council found that none of the evaluated models incorporated the ability to assess or compare prior imaging examinations, which limits utility in longitudinal or screening applications where interval change is critical [3]. Documenting input routing rules and the absence of prior-exam comparison is therefore part of integration evaluation, not a criticism of any single vendor.
A Suggested Routing Validation Scenario
A practice could design a limited trial around a single routing question: when a chest radiograph receives a positive triage signal, does it move to the intended queue position within the existing worklist driver? The scenario would use a defined set of studies with known routing attributes, record the timestamp when the AI result returns, and compare the observed queue position against the configured prioritization rule. The AMA guide's emphasis on documenting which systems receive the triage signal and how priorities are established provides the checklist for this test [4]. The IHE primer's description of a worklist driver application that balances factors across studies supplies the conceptual target [5].
This scenario would not measure diagnostic accuracy or clinical benefit. It would establish whether the integration path from AI output to worklist state is observable and reproducible. The limited trial framework supports this scope, since the intent is to assess the AI system as it integrates with relevant radiology systems [6]. If the practice cannot observe the routing event or cannot distinguish an in-progress result from an exception, that finding is itself an integration defect worth documenting before full deployment [6]. The scenario is a suggestion for structuring evaluation, not a claim that any specific product has been tested in this way.
Deployment Boundaries and Standards-Based Routing
The IHE primer distinguishes custom integrations from standards-based transactions. Accommodating custom integrations creates a substantial operational and maintenance burden and increases the likelihood of unanticipated problems [5]. The Prioritization of Worklists for Reporting profile defines standard transactions for AI models, the radiology information system, and other systems to feed a worklist driver application that balances factors across many studies [5]. This profile was recently released for trial implementation, which means its availability is documented but its adoption is not established. An evaluation can ask whether a proposed integration follows that profile or relies on proprietary interfaces, without assuming that standards compliance guarantees better clinical outcomes.
The Radiology AI Council observed a preference for models that could integrate directly into PACS via a vendor application programming interface, while models that store results permanently as DICOM secondary captures were less preferred due to suboptimal workflows and potential medicolegal concerns around persistence of results [3]. That preference reflects one institution's procurement reasoning, not a universal requirement. It does, however, illustrate a concrete deployment boundary: where results live and how long they persist affects both workflow and record ownership. An evaluation should ask whether triage results are transient routing signals or permanent study artifacts, because the answer changes who can later audit the prioritization decision.
What a Limited Trial Can and Cannot Establish
A limited trial is the first opportunity to evaluate an AI system prospectively within the clinical workflow, and it requires attention to both technical integration and user experience [6]. The framework separates validation, which is often retrospective, from limited trial, which is prospective and requires live product deployment at a smaller scale [6]. During a limited trial, an organization can observe whether the right studies and series are consistently routed to the AI system and whether results return in a timely and interpretable manner within existing PACS, dictation, or reporting environments [7]. Those are integration facts, not efficacy facts.
A limited trial cannot establish clinical benefit. The prospective study of AI-triaged worklists and AI-assisted report generation measured report generation time and turnaround time for chest radiographs, and the authors explicitly noted that diagnostic accuracy and report discrepancy rates were not assessed [2]. The same study found that the ability to act on triage signals immediately is contingent on available staffing [2]. A worklist evaluation should therefore state which outcomes are in scope: routing reliability, processing time, interface usability, and queue behavior. Claims about patient safety or diagnostic improvement require a different study design and should not be inferred from turnaround metrics alone.
Postdeployment Surveillance and Unresolved Questions
The Radiology AI Council reported that eleven companies had some form of postdeployment surveillance, but none had quantitative metrics or tools to assess ongoing performance [3]. The authors also stated that thoroughly vetted processes for monitoring do not yet exist [3]. This is a documented gap, not a vendor failure. An evaluation should ask who owns monitoring responsibility, whether the vendor, the client organization, or a shared model, and whether there is a defined process for model updates, communication, review, and approval [4]. The AMA guide also asks whether outputs are real-time, delayed, or batched, and how that timing affects time-sensitive decisions [4].
Several questions remain unresolved in the source material. The Radiology AI Council found no quantitative postdeployment tools among evaluated models, prompting development of an internal large language model-based system for ongoing performance assessment [3]. That internal system is described as a response to a gap, not as validated infrastructure. The outcomes review notes that current empirical evaluations of downstream patient and economic impacts are limited [8]. For worklist integration specifically, the unresolved questions are practical: whether triage signals persist in the record, how queue conflicts between multiple AI tools are resolved, and what happens when a flagged study arrives during a staffing shortage. These should be documented as open items rather than answered by assumption.
Sources & references
- acr–siim practice parameter for imaging artificial intelligence (ai) · gravitas.acr.org
- Impact of AI-Triaged Worklists and AI-Assisted Report Generation on Radiology Turnaround Times: Prospective Real-World Study · pmc.ncbi.nlm.nih.gov
- AI in Action: A Road Map From the Radiology AI Council for Effective Model Evaluation and Deployment - Journal of the American College of Radiology · www.jacr.org
- AI Specialty Collaborative: AI Evaluation Guide · www.ama-assn.org
- Integrating and Adopting AI in the Radiology Workflow: A Primer for Standards and Integrating the Healthcare Enterprise (IHE) Profiles | Radiology · pubs.rsna.org
- Does It Work, Help, and Stay? A Framework for Implementing Artificial Intelligence Tools in Radiology - ScienceDirect · www.sciencedirect.com
- Does It Work, Help, and Stay? A Framework for Implementing Artificial Intelligence Tools in Radiology - Journal of the American College of Radiology · www.jacr.org
- Radiology Workflow Assistance With Artificial Intelligence: Establishing the Link to Outcomes - Journal of the American College of Radiology · www.jacr.org